Science & Technology
Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatment
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1SB1CA287735-01A1
Award Ceiling
$250K
Award Floor
$250K
Close Date
Aug 31, 2026
169 days leftTotal Funding
$250K
Expected Awards
1
Posted Date
Sep 5, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1SB1CA287735-01A1
Description
SBIR Phase Phase II award: "Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatment" awarded to PDX PHARMACEUTICALS, INC. in PORTLAND, Oregon. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $250,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.